Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0604
-0.0006
(-0.98%)
At close: March 3 at 4:00:00 PM EST
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Kraig T. Higginson | President, CEO & Chairman of Board | -- | -- | 1956 |
| Mr. Ernest J. Scheidemann Jr. | Chief Financial Officer | -- | -- | 1961 |
| Mr. Stephen E. Quesenberry | General Counsel, Corporate Secretary & Director | -- | -- | 1964 |
Aspire Biopharma Holdings, Inc.
194 Candelero Drive
Suite 223
Humacao, PR 00791
United States
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company provides Sublingual Aspirin Product, which addresses cardiology emergencies and pain management. It develops formulation for a sublingually administered melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide, as well as formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and several other classes of drugs. The company was founded in 2021 and is based in Humacao, Puerto Rico.
Corporate Governance
Aspire Biopharma Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
JUNS Jupiter Neurosciences, Inc.
0.5835
-10.37%
TNFA TNF Pharmaceuticals, Inc.
0.3931
-5.98%
OSRH OSR Holdings, Inc.
2.6000
-14.47%
ADPT Adaptive Biotechnologies Corporation
8.10
-1.94%
SPRY ARS Pharmaceuticals, Inc.
10.18
-2.86%
DRUG Bright Minds Biosciences Inc.
34.92
-6.23%
AEON AEON Biopharma, Inc.
0.6100
-18.67%
PRAX Praxis Precision Medicines, Inc.
33.55
-13.08%
IVVD Invivyd, Inc.
0.9393
-19.03%
OCEA Ocean Biomedical, Inc.
0.0895
-10.50%